title: Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions.
abstract: A major concern inhibiting some clinicians from embracing peritoneal dialysis (PD) as the preferred first modality of dialysis is the effects of PD solutions on the peritoneal membrane. These anatomical and functional changes predispose to complications like peritonitis, encapsulating peritoneal sclerosis and ultrafiltration failure. In recent years, "biocompatible" and glucose-sparing PD regimens have been developed to minimize damage to the peritoneal membrane. Can the use of these more expensive solutions be justified on current evidence? In this review of the literature, we explore how we may individualize the prescription of biocompatible PD fluid.
authors: Ahad Qayyum, Klara Paudel, Stanley L Fan, Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.
authors: Ahad
authors: A
authors: Qayyum
authors: Ahad Qayyum, Klara Paudel, Stanley L Fan, Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.
authors: Elizabeth Ley
authors: EL
authors: Oei
authors: Ahad Qayyum, Klara Paudel, Stanley L Fan, Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.
authors: Klara
authors: K
authors: Paudel
authors: Ahad Qayyum, Klara Paudel, Stanley L Fan, Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.
authors: Stanley L
authors: SL
authors: Fan
keywords: Biocompatibility; Glucose degradation products; Individualized prescription; Peritoneal dialysis; Peritonitis; Residual renal function; Ultrafiltration failure